Barings LLC continued to hold its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 19,129 shares of the medical instruments supplier’s stock at the end of the second quarter. Barings LLC’s holdings in DENTSPLY SIRONA were worth $1,194,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Veritas Asset Management LLP increased its holdings in DENTSPLY SIRONA by 2.6% during the 2nd quarter. Veritas Asset Management LLP now owns 6,201,155 shares of the medical instruments supplier’s stock worth $402,083,000 after purchasing an additional 157,616 shares during the period. Bronfman E.L. Rothschild L.P. increased its holdings in DENTSPLY SIRONA by 78.7% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 11,886 shares of the medical instruments supplier’s stock worth $771,000 after purchasing an additional 5,236 shares during the period. Royce & Associates LP increased its holdings in DENTSPLY SIRONA by 23.4% during the 2nd quarter. Royce & Associates LP now owns 126,650 shares of the medical instruments supplier’s stock worth $8,212,000 after purchasing an additional 24,000 shares during the period. Gateway Investment Advisers LLC increased its holdings in DENTSPLY SIRONA by 8.4% during the 2nd quarter. Gateway Investment Advisers LLC now owns 19,408 shares of the medical instruments supplier’s stock worth $1,258,000 after purchasing an additional 1,499 shares during the period. Finally, Delta Lloyd Asset Management N.V. purchased a new position in DENTSPLY SIRONA during the 2nd quarter worth $15,624,000. Institutional investors own 93.88% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Barings LLC Maintains Stake in DENTSPLY SIRONA Inc. (XRAY)” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another website, it was illegally copied and republished in violation of United States and international copyright laws. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/10/11/barings-llc-maintains-stake-in-dentsply-sirona-inc-xray.html.

XRAY has been the topic of several research reports. UBS AG restated a “neutral” rating and set a $59.00 price objective (down from $62.00) on shares of DENTSPLY SIRONA in a report on Thursday, August 10th. BidaskClub downgraded DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Friday, July 28th. Jefferies Group LLC reduced their price objective on DENTSPLY SIRONA from $72.00 to $66.00 and set a “buy” rating on the stock in a report on Wednesday, August 23rd. Cleveland Research downgraded DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a report on Thursday, October 5th. Finally, Zacks Investment Research downgraded DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Monday, August 14th. Three research analysts have rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $65.89.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) opened at 57.57 on Wednesday. The stock’s market capitalization is $13.21 billion. DENTSPLY SIRONA Inc. has a one year low of $52.54 and a one year high of $65.68. The stock has a 50 day moving average price of $57.50 and a 200-day moving average price of $61.17.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.65. The business had revenue of $992.70 million for the quarter, compared to analysts’ expectations of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The company’s revenue for the quarter was down 2.9% compared to the same quarter last year. During the same period last year, the firm earned $0.76 earnings per share. Analysts anticipate that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current year.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Stock Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related stocks with our FREE daily email newsletter.